Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2/Phase 3"
topic_facet:"Carcinoma"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%2FPhase+3%22&filter%5B%5D=topic_facet%3A%22Carcinoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%2FPhase+3%22&filter%5B%5D=topic_facet%3A%22Carcinoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%2FPhase+3%22&filter%5B%5D=topic_facet%3A%22Carcinoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (71)
1
The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study : The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer : A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration Positive Patients With Stage IV Squamous Cell Lung Cancer (Lung-Map Sub-Study)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
3
Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer : A Phase II Study of AZD4547 for Previously Treated FGFR-Positive Patients With Stage IV Squamous Cell Lung Cancer (Lung-Map Sub-Study)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
4
An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC : A Randomized, Open-label, Multicentre, Phase II/III Study of Low-dose Long-term Continuous Intravenous Infused 5-fluorouracil Versus Gemcitabine Combined With Cisplatin and JS001 as First-line Therapy for Metastatic Nasopharyngeal Carcinoma
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
5
Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer : An Integrated Phase II/III, Open Label, Randomized and Controlled Study of the Safety and Efficacy of CG0070 Adenovirus Vector Expressing GM-CSF in Patients With NMIBC With Carcinoma In Situ Disease Who Have Failed BCG
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
6
Combination of Sintilimab and Stereotactic Body Radiotherapy in Hepatocellular Carcinoma (ISBRT01) : Effect of Stereotactic Body Radiotherapy Followed by Sintilimab Versus Stereotactic Body Radiotherapy Alone for Hepatocellular Carcinoma With Portal Vein Invasion After Arterially Directed Therapy: A Randomized Clinical Trial
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
7
Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma : Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy Versus Surgery Alone in Resectable Esophageal Squamous Cell Carcinoma
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
8
Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma : Combination Therapy of Microwave Ablation and Expanding Activated Autologous Lymphocytes for Hepatocellular Carcinoma
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
9
Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma : A Randomized Multicenter Phase II/III Study of Optimized Treatment Strategies for Stage II and III Nasopharyngeal Carcinoma
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
10
A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma. : A Randomized, Open-label,Multi-center Study to Evaluate the Efficacy and Safety of the Combination of Sintilimab and IBI305 Compared to Sorafenib in the First-Line Treatment of Patients With Advanced Hepatocellular Carcinoma. (ORIENT-32)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
1
2
3
4
5
6
7
8
Nächster »
[8]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 2/Phase 3
Filter aufheben
Thema: Carcinoma
Medienart
71
Aufsätze
71
E-Artikel
71
E-Ressourcen
Zeitschriftentitel
71
ClinicalTrials.gov
Thema
71
610
Carcinoma
Phase: Phase 2/Phase 3
71
Study Type: Interventional
29
Carcinoma, Hepatocellular
28
Recruitment Status: Completed
20
Medical Condition: Hepatocellular Carcinoma
16
Recruitment Status: Unknown status
8
Recruitment Status: Withdrawn
7
Nasopharyngeal Carcinoma
7
Recruitment Status: Terminated
6
Carcinoma, Squamous Cell
6
Recruitment Status: Recruiting
4
Carcinoma, Renal Cell
4
Carcinoma, Transitional Cell
3
Carcinoma, Basal Cell
3
Colorectal Neoplasms
3
Lung Neoplasms
3
Medical Condition: Nasopharyngeal Carcinoma
3
Recruitment Status: Not yet recruiting
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
14
2020-
53
2010-2019
4
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
71
Englisch
Haven't found what you're looking for?
Wird geladen...